HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Alpha-lactalbumin in "common" epithelial tumors of the ovary. An immunohistochemical study.

AbstractAlpha-lactalbumin (AL) has been widely used as an immunohistochemical marker for mammary carcinoma. The authors have investigated the AL reactivity of 36 unselected ovarian epithelial neoplasms using the avidin-biotin-peroxidase immunoperoxidase technic. In eight serous cystadenocarcinomas, both the primary neoplasm and its metastases were examined. Of the 36 tumors, 7 (19.4%) showed positive staining for AL and 5 were of the serous type. The serous tumors showed moderate to strong staining reaction. Three serous cystadenocarcinomas were AL positive in both primary and metastatic sites, while the remaining five were negative in all sites. One mucinous cystadenoma and one clear cell carcinoma showed weak to moderately positive AL reactivity. There was no good correlation between AL positivity and the presence of malignancy or between AL positivity and tumor grade. In view of the relatively high AL reactivity in ovarian neoplasms, it is advisable to exercise caution in interpreting the presence of AL positivity as specific marker for mammary carcinoma.
AuthorsM I Doria Jr, T Adamec, A Talerman
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 87 Issue 6 Pg. 752-6 (Jun 1987) ISSN: 0002-9173 [Print] UNITED STATES
PMID2438929 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lactalbumin
Topics
  • Carcinoma (metabolism, secondary)
  • Female
  • Histocytochemistry
  • Humans
  • Immunoenzyme Techniques
  • Lactalbumin (metabolism)
  • Ovarian Neoplasms (metabolism, secondary)
  • Staining and Labeling (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD